101 related articles for article (PubMed ID: 22614250)
1. Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.
Roszak A; Mostowska A; Sowińska A; Lianeri M; Jagodziński PP
Pathol Oncol Res; 2012 Oct; 18(4):997-1002. PubMed ID: 22614250
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients.
Grzegorzewska AE; Wobszal PM; Mostowska A; Jagodziński PP
BMC Nephrol; 2012 Aug; 13():75. PubMed ID: 22863216
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.
Morahan G; McKinnon E; Berry J; Browning B; Julier C; Pociot F; James I;
Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S64-8. PubMed ID: 19956104
[TBL] [Abstract][Full Text] [Related]
4. CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females.
Aierken K; Dong Z; Abulimiti T; Zhang Y; Abuduxikuer G; Tuerxun G; Abudurexiti G; Maimaitiaishan A; Mijiti P; Abulizi G
Mol Genet Genomic Med; 2019 May; 7(5):e626. PubMed ID: 30829464
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of IL-12/IL-23 axis is associated with coronary heart disease.
Dong J; Chen Q; Xie T; Wang M; Wang M; Zha L
J Cell Mol Med; 2024 Feb; 28(3):e18100. PubMed ID: 38189641
[TBL] [Abstract][Full Text] [Related]
6. The relationship between long non-coding gene
Han L; Liu J; Shataer M; Wu C; Niyazi M
Cancer Biol Ther; 2024 Dec; 25(1):2322207. PubMed ID: 38465665
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection.
Chansaenroj J; Theamboonlers A; Junyangdikul P; Swangvaree S; Karalak A; Chinchai T; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(1):341-6. PubMed ID: 23534750
[TBL] [Abstract][Full Text] [Related]
8. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer.
Zhang HL; Zhang YJ
Tumour Biol; 2013 Jun; 34(3):1659-65. PubMed ID: 23494178
[TBL] [Abstract][Full Text] [Related]
9. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis.
Zhou X; Gu Y; Zhang SL
Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080
[TBL] [Abstract][Full Text] [Related]
10. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.
Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G
Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between the FAS/FASL polymorphisms and cervical cancer risk: A meta-analysis.
DU Y; Hu L; Pan Y
Biomed Rep; 2013 Mar; 1(2):269-274. PubMed ID: 24648934
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.
Hussain SK; Madeleine MM; Johnson LG; Du Q; Galloway DA; Daling JR; Malkki M; Petersdorf EW; Schwartz SM
Int J Cancer; 2013 Jul; 133(1):201-13. PubMed ID: 23280621
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review.
Zhang X; Zhang L; Tian C; Yang L; Wang Z
BJOG; 2014 May; 121(6):664-74. PubMed ID: 24548744
[TBL] [Abstract][Full Text] [Related]
14. XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.
Pérez LO; Crivaro A; Barbisan G; Poleri L; Golijow CD
Pathol Oncol Res; 2013 Jul; 19(3):553-8. PubMed ID: 23539294
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.
Botezatu A; Socolov D; Iancu IV; Huica I; Plesa A; Ungureanu C; Anton G
J Cell Mol Med; 2013 Apr; 17(4):543-9. PubMed ID: 23444906
[TBL] [Abstract][Full Text] [Related]
16. Relationships of single nucleotide polymorphisms of monocyte chemoattractant protein 1 and chemokine receptor 2 with susceptibility and clinicopathologic characteristics of neoplasia of uterine cervix in Taiwan women.
Wu HH; Lee TH; Tee YT; Chen SC; Yang SF; Lee SK; Ko JL; Wang PH
Reprod Sci; 2013 Oct; 20(10):1175-83. PubMed ID: 23427179
[TBL] [Abstract][Full Text] [Related]
17. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.
Shi TY; Zhu ML; He J; Wang MY; Li QX; Zhou XY; Sun MH; Shao ZM; Yu KD; Cheng X; Wu X; Wei Q
Hum Genet; 2013 Mar; 132(3):301-12. PubMed ID: 23180271
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12B rs3212227 polymorphism and cancer risk: a meta-analysis.
Chen H; Cheng S; Wang J; Cao C; Bunjhoo H; Xiong W; Xu Y
Mol Biol Rep; 2012 Dec; 39(12):10235-42. PubMed ID: 23065198
[TBL] [Abstract][Full Text] [Related]
20. Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma.
Hong X; Li Y; Lv Q; An J; Liu Y; Wang X; Li R; Hu Y; Liu B
Int J Immunopathol Pharmacol; 2023; 37():3946320231172075. PubMed ID: 37073715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
